SESEN BIO, INC. closed the most recent trading day at $0.50, making no change from the previous trading session. This change lagged the S&P 500's 2.37% gain on the day. Meanwhile, the Dow gained 2.47%, and the Nasdaq, a tech-heavy index, lost 0.07%.
Prior to today's trading, shares of the company had gained 15.09% over the past month. This has outpaced the Medical sector's loss of 2.47% and the S&P 500's loss of 4.82% in that time.
Wall Street will be looking for positivity from SESEN BIO, INC. as it approaches its next earnings report date. On that day, SESEN BIO, INC. is projected to report earnings of -$0.08 per share, which would represent a year-over-year decline of 300%.
Investors might also notice recent changes to analyst estimates for SESEN BIO, INC.These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. SESEN BIO, INC. is currently a Zacks Rank #2 (Buy).
The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 54, which puts it in the top 22% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.